Caricamento...

Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines

Triple-negative breast cancer (TNBC) is the most challenging subtype to treat due to the lack of estrogen receptor, progesterone receptor, and HER2 expression, which excludes the usage of directed targeted therapy against them. Promising therapeutic targets are the hepatocyte growth factor receptor...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancers (Basel)
Autori principali: Simiczyjew, Aleksandra, Dratkiewicz, Ewelina, Van Troys, Marleen, Ampe, Christophe, Styczeń, Ilona, Nowak, Dorota
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2018
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6162814/
https://ncbi.nlm.nih.gov/pubmed/30227653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers10090335
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !